Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Final Guidance From FDA Maintains Relaxed Restrictions On Face Coverings

Executive Summary

The US Food and Drug Administration continues to ease up on rules around various types of face protectors and respirators throughout the duration of the COVID-19 pandemic, so long as they do not pose an undue risk to the public health and provide proper labeling.

You may also be interested in...



Disposable Masks Manufacturer Looks To Future Growth

Consumer demand for masks likely won’t slow following the pandemic, says DemeTECH VP Luis Arguello Jr. The PPE and medical equipment company has continued manufacturing masks despite supply chain disruptions and increased competition.

Potential Consumer Demand For Disposable Masks Poses Industry Promise And Marketplace Peril

Consumer demand for masks likely won’t slow following the pandemic, says DemeTECH VP Luis Arguello Jr. The maker of surgical and N95 masks as well as other personal protection and medical procedure equipment has continued manufacturing masks despite supply chain disruptions and competition from lower-cost imports that stymied some domestic firms.

Facing Shortage, FDA Further Relaxes Face Mask, Face Shield And Respirator Guidance

As the US heads into a COVID-19 storm with grave concerns about the lack of face masks and respirators for health care workers, the FDA has further relaxed federal oversight for such products, giving more responsibility to employers

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT144469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel